Small molecule inhibitors of lck sh2 domain binding

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

IPC codes

A61K 31/502 (2006.01) A61K 31/19 (2006.01) A61K 31/455 (2006.01) A61P 37/06 (2006.01)

Type

Patent

Patent number

CA 2696473

Description

The present invention provides, materials and methods for modulating an immune response. The materials and methods may be used to treat diseases associated with an aberrant immune response. In some embodiments, materials and methods of the invention may be used to treat autoimmune diseases, for example, rheumatoid arthritis.

L'invention concerne des matériaux et procédés pour moduler des réponses immunitaires. Les matériaux et procédés peuvent être utilisés pour traiter des maladies associées à une réponse immunitaire aberrante. Dans certains modes de réalisation, les matériaux et procédé de l'invention peuvent être utilisés pour traiter des maladies auto-immunitaires, par exemple la polyarthrite rhumatoïde.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Small molecule inhibitors of lck sh2 domain binding does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Small molecule inhibitors of lck sh2 domain binding, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecule inhibitors of lck sh2 domain binding will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1470884

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.